www.fdanews.com/articles/92504-astrazeneca-mulls-vaccine-sale-after-12-5bn-medimmune-deal
AstraZeneca Mulls Vaccine Sale After $12.5bn MedImmune Deal
April 26, 2007
AstraZeneca is already
considering offloading MedImmune's vaccines business, just days after it paid
$15.2bn (£7.6bn, E11.2bn) for the US biotech.
The
Business